Dubai, UAE, 2 April 2026 – Retinal disorders remain one of the leading causes …
Category:
Lifestyle & Health
-
-
Lifestyle & Healthslider
FDA approves Lilly’s Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions
by Karine Ayoubby Karine Ayoub• Adults taking Foundayo lost an average of 27 pounds on the highest dose in …
-
Lifestyle & HealthNGOslider
ECHO-funded WHO emergency shipment strengthens trauma care and chronic disease support in Lebanon
by Karine Ayoubby Karine AyoubBeirut, Lebanon – 31 March 2026 — More than 134 cubic meters of life-saving …
-
Lifestyle & Healthslider
Boehringer Ingelheim reports 11% growth in IMETA in 2025, led by continued momentum and innovation
by Karine Ayoubby Karine AyoubDubai, United Arab Emirates – April 2, 2026: Boehringer Ingelheim, one of the world’s …
-
Lifestyle & HealthsliderTourism & Hospitality
Celebrate Easter with a Family-Friendly Brunch at La Piscine,Al Raha Beach Resort & Spa
by Karine Ayoubby Karine AyoubUAE, Abu Dhabi – Dubai, March 2026: Al Raha Beach Resort & Spa invites …
-
EducationLifestyle & Healthslider
Ajman University and Sheikh Khalifa Hospitals Forge Strategic Partnership to Train Next Generation of UAE Healthcare Leaders
by Karine Ayoubby Karine AyoubAjman, UAE – 31 March 2026: In a significant step toward strengthening the UAE …
-
Lifestyle & Healthslider
NEW BRITISH COLLEGE OF COSMETIC SURGERY LAUNCHES College will Establish Official UK Fellowship in Cosmetic Surgery Excellence
by Karine Ayoubby Karine AyoubLondon, UK – 27th March 2026 – Announcing the official launch of the British College of …
-
Lifestyle & HealthsliderTourism & Hospitality
The H Dubai Has Your April Plans Covered with Dining, Wellness & City Breaks.
by Karine Ayoubby Karine AyoubSeasonal cakes, signature coffee, cocktail masterclasses, spa resets, and flexible staycations give plenty of …
-
ForumLifestyle & Healthslider
Third Edition of the Beauty & Wellbeing Forum – Lebanon 2026 is officially announced
by Karine Ayoubby Karine AyoubA message of Hope of Excellence from Lebanon to the world On Thursday morning, …
-
Lifestyle & Healthslider
Lilly’s oral GLP-1, orforglipron, delivered superior blood sugar control and weight loss compared to oral semaglutide in head-to-head type 2 diabetes trial published in The Lancet
by Karine Ayoubby Karine AyoubINDIANAPOLIS, March 24, 2026 — Eli Lilly and Company (NYSE: LLY) today announced detailed …